Search Platform

All Cases PTAB Litigations UPC Oppositions

The patent has been granted The patent has been granted, Grant of patent is intended, Examination is in progress, Request for examination was made EP Register Verified

MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS

Publication No. EP3868400

•

App No. EP21159529

•

Filed by Boehringer Ingelheim Animal Health USA Inc.

•

Filed on 2006-12-28

•

Issued/Published on 2026-05-13

Official EPO Register

Publication No. EP3868400 A1

Application No. EP21159529 Filed: 2006-12-28

Grant Date 2026-05-13 Mention of grant

Active Oppositions 1 Active EPO Oppositions

Patent Abstract / Summary

[0001] An improved method for recovering the protein expressed by open reading frame 2 from porcine circovirus type 2 is provided. Also provided is recombinant PCV2 ORF2 protein, and immunogenic compositions comprising PCV2 ORF2 protein. Moreover, multivalent combination vaccines are provided which include an immunological agent effective for reducing the incidence of or lessening the severity of PCV2 infection, preferably PCV2 ORF2 protein, or an immunogenic composition comprising PCV2 ORF2 protein, and at least one immunogenic active component of another disease-causing organism in swine,

IPC Classifications

A61K39/295, A61K39/04, A61K39/12, // C12N15/866

Priority Claims

US 20050755015P Date: 2005-12-29

Designated Contracting States (31 EPC States)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

Parties & Representation

Applicants

Boehringer Ingelheim Animal Health USA Inc.

3239 Satellite Blvd, Duluth, GA 30096

US

Inventors (5)

Eichmeyer, Marc Allan

BOEHRINGER INGELHEIM VETMEDICA, INC., 2621 North Belt Highway

US

Hayes, Phillip Wayne

BOEHRINGER INGELHEIM VETMEDICA, INC., 2621 North Belt Highway

US

Nitzel, Greg

BOEHRINGER INGELHEIM VETMEDICA, INC., 2621 North Belt Highway

US

Roof, Michael B.

BOEHRINGER INGELHEIM VETMEDICA, INC., 2621 North Belt Highway

US

Schaeffer, Merrill Lynn

BOEHRINGER INGELHEIM VETMEDICA, INC., 2621 North Belt Highway

US

Representatives / Agents

Hoffmann Eitle

Patent- und Rechtsanwälte PartmbB, Arabellastraße 30

DE

Grünecker Patent- und Rechtsanwälte PartG mbB

Leopoldstraße 4, 80802 München

DE

Key Procedural Dates

Request-For-Examination 2021-02-26

Mention Of Grant Published 2026-05-13

First-Examination-Report-Despatched 2023-08-16

Legal Status & Event History

Official European Patent Office legal and procedural status changes recorded for this file.

39 Events Recorded

Date	Code	Event Description	Auth
2021-08-25	17P	REQUEST FOR EXAMINATION FILED	EP
2021-08-25	AC	DIVISIONAL APPLICATION: REFERENCE TO EARLIER APPLICATION	EP
2021-08-25	AK	DESIGNATED CONTRACTING STATES	EP
2021-07-23	PUAI	PUBLIC REFERENCE MADE UNDER ARTICLE 153(3) EPC TO A PUBLISHED INTERNATIONAL APPLICATION THAT HAS ENTERED THE EUROPEAN PHASE	EP
2021-07-23	STAA	INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT	EP
2023-04-25	TPAC	OBSERVATIONS FILED BY THIRD PARTIES	EP
2023-06-19	TPAC	OBSERVATIONS FILED BY THIRD PARTIES	EP
2023-08-11	STAA	INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT	EP
2023-09-13	17Q	FIRST EXAMINATION REPORT DESPATCHED	EP
2024-05-29	TPAC	OBSERVATIONS FILED BY THIRD PARTIES	EP
2025-04-16	TPAC	OBSERVATIONS FILED BY THIRD PARTIES	EP
2026-01-21	TPAC	OBSERVATIONS FILED BY THIRD PARTIES	EP
2026-03-06	GRAP	DESPATCH OF COMMUNICATION OF INTENTION TO GRANT A PATENT	EP
2026-03-06	STAA	INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT	EP
2026-03-07	GRAS	GRANT FEE PAID	EP
2026-03-11	TPAC	OBSERVATIONS FILED BY THIRD PARTIES	EP
2026-03-13	TPAC	OBSERVATIONS FILED BY THIRD PARTIES	EP
2026-03-14	TPAC	OBSERVATIONS FILED BY THIRD PARTIES	EP
2026-03-18	RIC1	INFORMATION PROVIDED ON IPC CODE ASSIGNED BEFORE GRANT	EP
2026-03-25	RIC1	INFORMATION PROVIDED ON IPC CODE ASSIGNED BEFORE GRANT	EP
2026-04-02	TPAC	OBSERVATIONS FILED BY THIRD PARTIES	EP
2026-04-08	INTG	INTENTION TO GRANT ANNOUNCED	EP
2026-04-10	STAA	INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT	EP
2026-04-10	GRAA	(EXPECTED) GRANT	EP
2026-05-13	AC	DIVISIONAL APPLICATION: REFERENCE TO EARLIER APPLICATION	EP
2026-05-13	AK	DESIGNATED CONTRACTING STATES	EP
2026-05-13	REG	REFERENCE TO A NATIONAL CODE	EP
2026-05-22	PLBI	OPPOSITION FILED	EP
2026-05-28	REG	REFERENCE TO A NATIONAL CODE	EP
2026-06-03	REG	REFERENCE TO A NATIONAL CODE	EP
2026-06-24	26	OPPOSITION FILED	EP
2026-07-27	REG	REFERENCE TO A NATIONAL CODE	EP
2026-08-12	REG	REFERENCE TO A NATIONAL CODE	EP
2026-08-19	P01	OPT-OUT OF THE COMPETENCE OF THE UNIFIED PATENT COURT (UPC) REGISTERED	EP
2026-08-19	REG	REFERENCE TO A NATIONAL CODE	EP
2026-09-22	PG25	LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO]	EP
2026-10-09	PG25	LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO]	EP
2026-10-10	PG25	LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO]	EP
2026-10-12	REG	REFERENCE TO A NATIONAL CODE	EP

Patent & Non-Patent Citations

Cited documents and prior art referenced in search and examination reports.

81 Citations

Cited Patent Documents

US3479705

Espacenet

US6703023

Espacenet

US2909462

Espacenet

US4708871

Espacenet

US7122192

Espacenet

WO9307898

Espacenet

WO9418311

Espacenet

GB2282811

Espacenet

FR2709966

Espacenet

WO0001409

Espacenet

EP0597852

Espacenet

EP0550477

Espacenet

EP0571648

Espacenet

WO0116330

Espacenet

WO2007076520

Espacenet

CA2784260

Espacenet

EP2275132

Espacenet

WO2006072065

Espacenet

US2004161410

Espacenet

US2003170270

Espacenet

WO2005009462

Espacenet

WO2017162727

Espacenet

Non-Patent Scientific Literature (NPL)

- MINION ET AL., J. BACTERIOL., vol. 186, 2004, pages 7123 - 33

- VASCONCELOS ET AL., J. BACTERIOL., vol. 187, 2005, pages 5568 - 77

- JOURNAL OF GENERAL VIROLOGY, vol. 81, 2000, pages 2281 - 2287

- "Genbank", Database accession no. AF086834

- HUNTER ET AL.: "Vaccine Design, The Subunit and Adjuvant Approach", 1995, JOHNWILEY AND SONS, pages: 51 - 94

- TODD ET AL., VACCINE, vol. 15, 1997, pages 564 - 570

- PHAMEUROPA, vol. 8, no. 2, June 1996 (1996-06-01)

- CARILLO, H.LIPMAN, D.: "Computational Molecular Biology", vol. 48, 1988, OXFORD UNIVERSITY PRESS, pages: 1073

- BERGMANN ET AL., EUR. J. IMMUNOL., vol. 23, 1993, pages 2777 - 2781

- "Computer Analysis of Sequence Data", 1994, HUMANA PRESS

- VON HEINGE, G.: "Sequence Analysis in Molecular Biology", 1987, ACADEMIC PRESS

- "Sequence Analysis Primer", 1991, M. STOCKTON PRESS

- DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, vol. 12, no. 1, 1984, pages 387

- ALTSCHUL, S. F. ET AL., J. MOLEC. BIOL., vol. 215, 1990, pages 403 - 410

- ALTSCHUL, S. ET AL.: "Remington's Pharmaceutical Sciences", 1990, NCVI NLM NIH

- BERGMANN ET AL., J. IMMUNOL., vol. 157, 1996, pages 3242 - 3249

- GEYSEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 3998 - 4002

- GEYSEN ET AL., MOLEC. IMMUNOL., vol. 23, 1986, pages 709 - 715

- SUHRBIER, A., IMMUNOL. AND CELL BIOL., vol. 75, 1997, pages 402 - 408

- GARDNER ET AL., 12TH WORLD AIDS CONFERENCE, 1998

- BLANCHARD, P. MAHE, D. CARIOLET, R. KERANFLEC'H, A. BAUDOUARD, M.A. CORDIOLI, P. ALBINA, E. JESTIN, A.: "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, vol. 21, no. 31, 7 November 2003 (2003-11-07), AMSTERDAM, NL , pages 4565 - 4575, XP004467337, ISSN: 0264-410X, DOI: 10.1016/S0264-410X(03)00503-6

- C CHARREYRE, A BRUN, C AERBERLE, L BOEUF, P BROCARD AND G CHAPPUIS: "Vaccination challenge trials with an inactivated vaccine against PRRS", PROCEEDINGS OF THE 15TH IPVS CONGRESS, 5 July 1998 (1998-07-05) - 9 July 1998 (1998-07-09), pages 1392, XP055525284

- JIWOON JEONG, HEI SUK KANG, CHANGHOON PARK, HWI WON SEO, IKJAE KANG, KYUHYUNG CHOI, CHANHEE CHAE: "Comparative efficacy of concurrent administration of a porcine circovirus type 2 (PCV2) vaccine plus a porcine reproductive and respiratory syndrome virus (PRRSV) vaccine from two commercial sources in pigs challenged with both viruses", J. SWINE HEALTH AND PRODUCTION, vol. 24, 1 June 2016 (2016-06-01), pages 130 - 141, XP055525287

- BAHNEMANN H. G.: "INACTIVATION OF VIRUSES IN SERUM WITH BINARY ETHYLENEIMINE.", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 03., no. 02., 1 February 1976 (1976-02-01), US , pages 209/210., XP002914056, ISSN: 0095-1137

- REYNAUD, G. ET AL., PROCEEDINGS OF THE 15TH IPVS CONGRESS, INTERNATIONAL PIG VETERINARY SOCIETY ; BIRMINGHAM, UNITED KINGDOM; JULY 5-9, 1998, 1998, pages 150, XP009544513, ISBN: 1-897676-87-5

- MARTINON.O.: "Efficacy of a Mycoplasma Hyopneumonia Bacterin (Hyoresp) in Challenge Studies", PROCEEDINGS OF THE 15TH IPVS CONGRESS, INTERNATIONAL PIG VETERINARY SOCIETY ; BIRMINGHAM, UNITED KINGDOM; JULY 5-9, 1998, 1998, pages 157, XP055582115

- MARTINON, O.; TIBERGHIEN, M.P.; REYNAUD, G.; BLANCHET, M.; BRUN, A.; MILWARD, F.: "Efficacy of a 'One Shot' Schedule of a Mycoplasma hyopneumoniae Bacterin (Hyoresp)", PROCEEDINGS OF THE 15TH IPVS CONGRESS, INTERNATIONAL PIG VETERINARY SOCIETY ; BIRMINGHAM, UNITED KINGDOM; JULY 5-9, 1998, 1 January 1998 (1998-01-01) - 9 July 1998 (1998-07-09), pages 284, XP009544512, ISBN: 1-897676-87-5

- MARTINON, O.; TIBERGHIEN, M.P.; REYNAUD, G.; BLANCHET, M.; BRUN, A.; MILWARD, F. , PROCEEDINGS OF THE 15TH IPVS CONGRESS, INTERNATIONAL PIG VETERINARY SOCIETY ; BIRMINGHAM, UNITED KINGDOM; JULY 5-9, 1998, vol. 15, 1 January 1998 (1998-01-01) - 9 July 1998 (1998-07-09), pages 285, XP009544511

- A. P. SCHINCKEL, ET AL: "Analysis of Pig Growth from Birth to Sixty Days of Age", SWINE RESEARCH REPORT. PURDUE UNIVERSITY, AMERICAN REGISTRY OF PROFESSIONAL ANIMAL SCIENTISTS, 1 January 2003 (2003-01-01), pages 57 - 67, XP055277371, Retrieved from the Internet <URL:http://www.ansc.purdue.edu/swine/swineday/sday03/10.pdf> [retrieved on 20160602]

- MICHAEL HAAKE ET AL: "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", VETERINARY MICROBIOLOGY, vol. 168, no. 2-4, 1 January 2014 (2014-01-01), pages 272 - 280, XP055155313, ISSN: 0378-1135, DOI: 10.1016/j.vetmic.2013.11.012

- BLANCHARD P ET AL: "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 21, no. 31, 7 November 2003 (2003-11-07), pages 4565 - 4575, XP004467337, ISSN: 0264-410X

- MICHAEL HAAKE, ANDREAS PALZER, BEATE RIST, CHRISTIANE WEISSENBACHER-LANG, VICKY FACHINGER, ALEX EGGEN, MATHIAS RITZMANN, MATTHIAS : "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", VET. MICROBIOL., vol. 168, 1 January 2013 (2013-01-01), pages 1 - 9, XP055502963

- FENAUX M, ET AL.: "A CHIMERIC PORCINE CIRCOVIRUS (PCV) WITH THE IMMUNOGENIC CAPSID GENE FOR THE PATHOGENIC PCV TYPE 2 (PCV2) CLONED INTO THE GENOMIC BACKBONE OF THE NONPATHOGENIC PCV1 INDUCES PROTECTIVE IMMUNITY AGAINST PCV2 INFECTION IN PIGS", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 78, no. 12, 1 June 2004 (2004-06-01), US , pages 6297 - 6303, XP008039321, ISSN: 0022-538X, DOI: 10.1128/JVI.78.12.6297-6303.2004

- BLANCHARD, P. MAHE, D. CARIOLET, R. KERANFLEC'H, A. BAUDOUARD, M.A. CORDIOLI, P. ALBINA, E. JESTIN, A.: "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 21, no. 31, 7 November 2003 (2003-11-07), AMSTERDAM, NL , pages 4565 - 4575, XP004467337, ISSN: 0264-410X, DOI: 10.1016/S0264-410X(03)00503-6

- D10 - Declaration of Merrill L. Schaeffer, Ph.D. dated 20 March 2017

- MCKEOWN N. E., OPRIESSNIG T., THOMAS P., GUENETTE D. K., ELVINGER F., FENAUX M., HALBUR P. G., MENG X. J.: "Effects of Porcine Circovirus Type 2 (PCV2) Maternal Antibodies on Experimental Infection of Piglets with PCV2", CLINICAL AND VACCINE IMMUNOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 12, no. 11, 1 November 2005 (2005-11-01), pages 1347 - 1351, XP093400597, ISSN: 1556-6811, DOI: 10.1128/cdli.12.11.1347-1351.2005

- URNIZA A., M. BALASCH, Z. XU, H.J. CHU, J. PLANA-DURAN: "Duration of immunity study in pigs vaccinated with an inactivated/adjuvanted vaccine chimeric porcine circovirus type1/type2 in front of a challenge with PCV2 European strain", PROCEEDINGS OF THE 19TH IPVS CONGRESS, vol. 2, 1 July 2006 (2006-07-01), pages 108, XP093400600

- D12a - Proof of Date of D12

- FACHINGER VICKY ET AL: "The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex.", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 26, no. 11, 10 March 2008 (2008-03-10), AMSTERDAM, NL , pages 1488 - 1499, XP002473149, ISSN: 0264-410X

- KIXMOLLER, M. ; RITZMANN, M. ; EDDICKS, M. ; SAALMULLER, A. ; ELBERS, K. ; FACHINGER, V.: "Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 26, no. 27-28, 25 June 2008 (2008-06-25), AMSTERDAM, NL , pages 3443 - 3451, XP022710551, ISSN: 0264-410X, DOI: 10.1016/j.vaccine.2008.04.032

- T. OPRIESSNIG, PATTERSON A. R., ELSENER J., MENG X. J., HALBUR P. G.: "Influence of Maternal Antibodies on Efficacy of Porcine Circovirus Type 2 (PCV2) Vaccination To Protect Pigs from Experimental Infection with PCV2", CLINICAL AND VACCINE IMMUNOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 15, no. 3, 1 March 2008 (2008-03-01), pages 397 - 401, XP055225680, ISSN: 1556-6811, DOI: 10.1128/CVI.00416-07

- D16 - Excerpt from Intervet International R&D study, 2011

- D17 - Excerpt from Intervet International R&D study, 2012

- D18 - Memo reflecting results of R&D study, 2012

- ANONYMOUS: "Boehringer Ingelheim introduces DiaTEC, a new and proprietary purification technology for Ingelvac CircoFLEX", BOEHRINGER INGELHEIM, 3 January 2020 (2020-01-03), XP093400613, Retrieved from the Internet <URL:https://www.boehringer-ingelheim.com/media-stories/press-releases/diatec-new-purification-technology-ingelvac-circoflex>

- ANONYMOUS: "FLEX CircoPRRS - Porcine Reproductive and Respiratory Syndrome - Porcine Circovirus Type 2 Vaccine, Modified-Live Virus, Killed Baculavirus Vector", BOEHRINGER INGELHEIM, 1 January 2023 (2023-01-01), XP093400618

- SIEGRIST CLAIRE-ANNE: "Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 21, no. 24, 28 July 2003 (2003-07-28), AMSTERDAM, NL , pages 3406 - 3412, XP093400621, ISSN: 0264-410X, DOI: 10.1016/s0264-410x(03)00342-6

- THOMAS PETER, TANJA OPRIESSNIG, NICHOLE MCKEOWN, XIANG-JIN MENG, PATRICK G. HALBUR: "Effect of PCV2 passive antibody levels on immunization with chimeric PCV1-2 vaccine and challenge With Wild-type PCV2", AMERICAN ASSOCIATION OF SWINE VETERINARIANS, 1 January 2005 (2005-01-01), pages 23 - 25, XP093362966

- D24 - T 1415/16

- D27 - T 860/21

- D28 - T 0106/24

- D29 - T 1523/24

- HUIYING FAN ET AL: "Baculovirus insect expression and immunological studies of porcin circovirus type 2 capsid protein", PROC. 2ND ASIAN PIG VET. SOC. CONGRESS, 1 January 2005 (2005-01-01) - 21 September 2005 (2005-09-21), pages 186 - 188, XP055292703

- ANONYMOUS: "Ingelvac® CircoFLEX™", BOEHRINGER INGELHEIM - TECHNICAL BULLETIN, 1 January 2006 (2006-01-01), XP055736386

- D25 - T 2410/19

- "ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS: Ingelvac CircoFLEX suspensions for injections for pigs; EPAR product information; European Medical Agency", 13 February 2008 (2008-02-13), XP055165805, Retrieved from the Internet <URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000126/WC500062388.pdf>

- D26 - T 2353/19

- FACHINGER VICKY ET AL: "The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 26, no. 11, 10 March 2008 (2008-03-10), pages 1488 - 1499, XP002473149, ISSN: 0264-410X

- KIXMOLLER M ET AL: "Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 26, no. 27-28, 25 June 2008 (2008-06-25), pages 3443 - 3451, XP022710551, ISSN: 0264-410X, [retrieved on 20080505], DOI: 10.1016/J.VACCINE.2008.04.032

Worldwide Patent Family

Related applications and patents in the same INPADOC worldwide family.

74 Family Members

Country	Publication Number	Kind	Publication Date	Action
EP	EP3868400A1	A1	2021-08-25	Espacenet
EP	EP3868400B1	B1	2026-05-13	Espacenet
AR	AR058870A1	A1	2008-02-27	Espacenet
AU	AU2006330491A1	A1	2007-07-05	Espacenet
AU	AU2006330491B2	B2	2011-08-18	Espacenet
BR	BR122015028489B1	B1	2021-10-13	Espacenet
BR	BRPI0620859A2	A2	2011-11-22	Espacenet
CA	CA2635598A1	A1	2007-07-05	Espacenet
CA	CA2635598C	C	2020-10-13	Espacenet
CN	CN101389350A	A	2009-03-18	Espacenet
CN	CN101389350B	B	2013-11-13	Espacenet
CN	CN102698263A	A	2012-10-03	Espacenet
CN	CN102698263B	B	2016-07-06	Espacenet
CN	CN103536914A	A	2014-01-29	Espacenet
CN	CN103536914B	B	2015-11-11	Espacenet
DK	DK1968630T3	T3	2018-04-23	Espacenet
DK	DK1968630T5	T5	2018-08-13	Espacenet
DK	DK2275132T3	T3	2021-05-17	Espacenet
DK	DK3320919T3	T3	2020-08-03	Espacenet
DK	DK3868400T3	T3	2026-07-27	Espacenet
EP	EP1968630A2	A2	2008-09-17	Espacenet
EP	EP1968630A4	A4	2008-12-24	Espacenet
EP	EP1968630B1	B1	2018-01-24	Espacenet
EP	EP2275132A2	A2	2011-01-19	Espacenet
EP	EP2275132A3	A3	2011-04-20	Espacenet
EP	EP2275132B1	B1	2021-03-03	Espacenet
EP	EP3320919A1	A1	2018-05-16	Espacenet
EP	EP3320919B1	B1	2020-05-27	Espacenet
ES	ES2666451T3	T3	2018-05-04	Espacenet
ES	ES2814473T3	T3	2021-03-29	Espacenet
ES	ES2870583T3	T3	2021-10-27	Espacenet
ES	ES3076668T3	T3	2026-08-19	Espacenet
HU	HUE037267T2	T2	2018-08-28	Espacenet
HU	HUE051025T2	T2	2021-01-28	Espacenet
HU	HUE054868T2	T2	2021-10-28	Espacenet
JP	JP2009522309A	A	2009-06-11	Espacenet
JP	JP5394750B2	B2	2014-01-22	Espacenet
JP	JP2013241465A	A	2013-12-05	Espacenet
KR	KR20080083193A	A	2008-09-16	Espacenet
KR	KR101436794B1	B1	2014-09-04	Espacenet
MX	MX365868B	B	2019-06-18	Espacenet
MY	MY149398A	A	2013-08-30	Espacenet
MY	MY180002A	A	2020-11-19	Espacenet
PH	PH12014502525A1	A1	2016-01-18	Espacenet
PH	PH12014502525B1	B1	2016-01-18	Espacenet
PL	PL1968630T3	T3	2018-08-31	Espacenet
PL	PL2275132T3	T3	2021-09-13	Espacenet
PL	PL3320919T3	T3	2020-11-30	Espacenet
PT	PT1968630T	T	2018-04-12	Espacenet
PT	PT2275132T	T	2021-05-21	Espacenet
PT	PT3320919T	T	2020-09-03	Espacenet
RU	RU2008130927A	A	2010-02-10	Espacenet
RU	RU2488407C2	C2	2013-07-27	Espacenet
RU	RU2013113299A	A	2014-10-10	Espacenet
RU	RU2577127C2	C2	2016-03-10	Espacenet
RU	RU2013114405A	A	2014-10-10	Espacenet
RU	RU2577129C2	C2	2016-03-10	Espacenet
TW	TW200733973A	A	2007-09-16	Espacenet
TW	TWI528970B	B	2016-04-11	Espacenet
UA	UA99708C2	C2	2012-09-25	Espacenet
US	US2018169213A1	A1	2018-06-21	Espacenet
US	US10624963B2	B2	2020-04-21	Espacenet
US	US2008226669A1	A1	2008-09-18	Espacenet
US	US2009092636A1	A1	2009-04-09	Espacenet
US	US8119143B2	B2	2012-02-21	Espacenet
US	US2012107348A1	A1	2012-05-03	Espacenet
US	US9101561B2	B2	2015-08-11	Espacenet
US	US2015297707A1	A1	2015-10-22	Espacenet
US	US9925255B2	B2	2018-03-27	Espacenet
US	US2015297708A1	A1	2015-10-22	Espacenet
US	US9925256B2	B2	2018-03-27	Espacenet
WO	WO2007076520A2	A2	2007-07-05	Espacenet
WO	WO2007076520A3	A3	2007-12-27	Espacenet
ZA	ZA200804957B	B	2009-08-26	Espacenet

Official File Inspection EPC Art. 128 Public Dossier

Complete European Patent Register Dossier (148 Total Documents)

The full inspection file for Application EP21159529 contains 148 total documents, including all notices of opposition, proprietor counter-statements, examination communications, third-party observations, and procedural forms. Below are all major recorded procedural filings and publication specifications.

Open 148-Doc Register Dossier

Recorded Filings & Patent Specifications

Official publication specifications, opposition filings, proprietor replies, and procedural submissions.

68 Filings Listed

European Patent Specification - Granted Patent (B1)

Publication Specification

Date: 2026-05-13 Procedure: Grant EP3868400B1

View / Download PDF

Official European Patent Register Full Dossier

Publication Specification

Date: 2026-05-13 Procedure: All Proceedings (Examination & Opposition) EP21159529

View / Download PDF

European Patent Application with Search Report (A1)

Publication Specification

Date: 2021-08-25 Procedure: Publication EP3868400A1

View / Download PDF

Lapse of the patent in a contracting state

Dossier Filing

Date: 2026-09-25 Procedure: Examination 0009250

Inspect on Register

Opposition filed

Dossier Filing

Date: 2026-05-22 Procedure: Opposition 0009260

Inspect on Register

(Expected) grant

Dossier Filing

Date: 2026-04-10 Procedure: Grant 0009210

Inspect on Register

New entry: Observations by third parties

Dossier Filing

Date: 2026-04-02 Procedure: Examination EPIDOSNTIPA

Inspect on Register

Observations by a third party

Procedural Step

Date: 2026-03-31 Procedure: Examination TIPA

Inspect on Register

New entry: Observations by third parties

Dossier Filing

Date: 2026-03-14 Procedure: Examination EPIDOSNTIPA

Inspect on Register

New entry: Observations by third parties

Dossier Filing

Date: 2026-03-13 Procedure: Examination EPIDOSNTIPA

Inspect on Register

Observations by a third party

Procedural Step

Date: 2026-03-12 Procedure: Examination TIPA

Inspect on Register

New entry: Observations by third parties

Dossier Filing

Date: 2026-03-11 Procedure: Examination EPIDOSNTIPA

Inspect on Register